Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
CA 3043000
DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE
granted -
US 9969975
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9970006
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
granted -
US 9968693
Small molecule imaging of fungi by positron emission tomography scanning
granted -
US 9968664
Fusion molecule based on novel TAA variant
granted -
US 9963700
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 9963699
Methods for modulating C9ORF72 expression
granted -
US 9963515
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
granted -
US 9957292
Compositions and methods for modulating angiopoietin-like 3 expression
granted -
US 9957507
Compositions and methods for inhibiting expression of mutant EGFR gene
granted -
US 9957504
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 9957501
Nuclease-mediated regulation of gene expression
granted -
US 9957569
Recurrent gene fusions in prostate cancer
granted -
US 9950011
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950010
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9944926
Induced exon inclusion in spinal muscle atrophy
granted -
US 9938531
Compositions and methods for inhibiting expression of RRM2 genes
granted -
US 9938353
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
granted -
US 9938344
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 9938582
Recurrent gene fusions in prostate cancer
granted -
US 9932589
EML4-ALK fusion gene
granted -
US 9932581
Compositions and methods for modulating apolipoprotein C-III expression
granted -
US 9932593
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted -
US 9932580
Compositions and methods for modulating HBV expression
granted